Fintech– 0

TuHURA Biosciences reports Q4, FY25 results

Prnewswire·April 1, 2026 at 11:45 AM

TuHURA Biosciences, Inc. has released its financial results for the fourth quarter and full year of 2025, alongside a corporate update. The company, which is developing novel therapeutics for immuno-oncology, provided insights into its performance and strategic direction. Investors are reviewing these results for indications of progress in its clinical pipeline and overall financial health as it advances its late-stage development programs.

Tickers

$HURA

TuHURA Biosciences reports Q4, FY25 results

Companies Balance AI Opportunities With Fear of Bubble

Sona Secures $45 Million for AI Platform Expansion

Tariffs Reshape Business Strategy One Year Later

eToro launches crypto trading in New York